Trastuzumab and Oxaliplatin in Patients With Metastatic Breast Cancer
Clinical trial NCT00297596 · COMPLETED
Trial details
- NCT number
- NCT00297596
- Sponsor
- SCRI Development Innovations, LLC
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2006-02-01
- Primary completion
- 2008-10-01
- Enrollment
- 25
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.